These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 8634025

  • 1. Human T-cell lymphotropic virus types I and II infections in patients with leukaemia/lymphoma and in subjects with sexually transmitted diseases in Nigeria.
    Olaleye OD, Ekweozor CC, Li ZL, Opala IE, Sheng Z, Onyemenem TN, Rasheed S.
    Arch Virol; 1996; 141(2):345-55. PubMed ID: 8634025
    [Abstract] [Full Text] [Related]

  • 2. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
    Wang HR, Yan YS, Zhang QW, Zheng J, Liu JM, Feng YY, Wu SQ, Wu JH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
    [Abstract] [Full Text] [Related]

  • 3. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
    Segurado AA, Malaque CM, Sumita LM, Pannuti CS, Lal RB.
    Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
    [Abstract] [Full Text] [Related]

  • 4. [Prevalence, risk factors and genetic characterization of human T-cell lymphotropic virus types 1 and 2 in patients infected with human immunodeficiency virus type 1 in the cities of Ribeirão Preto and São Paulo].
    Kleine Neto W, Sanabani SS, Jamal LF, Sabino EC.
    Rev Soc Bras Med Trop; 2009 Aug; 42(3):264-70. PubMed ID: 19684973
    [Abstract] [Full Text] [Related]

  • 5. Evidence of serological cross-reactivities with human immunodeficiency virus types 1 and 2 and human T-lymphotropic virus types I and II in sera of pregnant women in Ibadan, Nigeria.
    Olaleye DO, Ekweozor CC, Sheng Z, Rasheed S.
    Int J Epidemiol; 1995 Feb; 24(1):198-203. PubMed ID: 7797344
    [Abstract] [Full Text] [Related]

  • 6. Human T lymphotropic virus (HTLV) type I and II DNA amplification in HTLV-I/II-seropositive blood donors of the French West Indies.
    Wattel E, Mariotti M, Agis F, Gordien E, Prou O, Courouce AM, Rouger P, Wain-Hobson S, Chen IS, Lefrère JJ.
    J Infect Dis; 1992 Feb; 165(2):369-72. PubMed ID: 1730903
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections in HTLV-I/II-seropositive individuals.
    Heneine W, Khabbaz RF, Lal RB, Kaplan JE.
    J Clin Microbiol; 1992 Jun; 30(6):1605-7. PubMed ID: 1624585
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Type-specific immune response to human T cell lymphotropic virus (HTLV) type I and type II infections in Nigeria.
    Olaleye DO, Bernstein L, Sheng Z, Ekweozor CC, Li XY, Sullivan-Halley J, Rasheed S.
    Am J Trop Med Hyg; 1994 Apr; 50(4):479-86. PubMed ID: 8166356
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Detection of human T-lymphotropic virus (HTLV) tax sequences in New York City blood donors seronegative for HTLV types 1 and 2.
    Dezzutti CS, Guenthner PC, Daniel S, Utz U, Cabrera T, Marshall JH, Bianco C, Lal RB, Cowan EP.
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):715-7. PubMed ID: 12853410
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
    Mangano AM, Remesar M, del Pozo A, Sen L.
    J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
    [Abstract] [Full Text] [Related]

  • 15. [Human T-lymphotropic virus I/II detection in Chilean patients from Sexually Transmitted Diseases clinics].
    Sanhueza D, Ramírez E, Navarrete N, Santander E, Garmendia ML, Martínez MJ.
    Rev Med Chil; 2012 Oct; 140(10):1239-44. PubMed ID: 23559279
    [Abstract] [Full Text] [Related]

  • 16. Determination of the true prevalence of infection with the human T-cell lymphotropic viruses (HTLV-I/II) may require a combination of biomolecular and serological analyses.
    Pancake BA, Zucker-Franklin D, Marmor M, Legler PM.
    Proc Assoc Am Physicians; 1996 Nov; 108(6):444-8. PubMed ID: 8956367
    [Abstract] [Full Text] [Related]

  • 17. Comparative performances of serologic and molecular assays for detecting human T lymphotropic virus type 1 and type 2 (HTLV-1 and HTLV-2) in patients infected with human immunodeficiency virus type 1 (HIV-1).
    Campos KR, Gonçalves MG, Costa NA, Caterino-de-Araujo A.
    Braz J Infect Dis; 2017 Nov; 21(3):297-305. PubMed ID: 28343818
    [Abstract] [Full Text] [Related]

  • 18. HTLV-I and HTLV-II infections in hematologic disorder patients, cancer patients, and healthy individuals from Rio de Janeiro, Brazil.
    Farias de Carvalho SM, Pombo de Oliveira MS, Thuler LC, Rios M, Coelho RC, Rubim LC, Silva EM, Reis AM, Catovsky D.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jul 01; 15(3):238-42. PubMed ID: 9257659
    [Abstract] [Full Text] [Related]

  • 19. A new endemic focus of human T lymphotropic virus type II carriers among Orinoco natives in Colombia.
    Fujiyama C, Fujiyoshi T, Miura T, Yashiki S, Matsumoto D, Zaninovic V, Blanco O, Harrington W, Byrnes JJ, Hayami M.
    J Infect Dis; 1993 Oct 01; 168(4):1075-7. PubMed ID: 8376825
    [No Abstract] [Full Text] [Related]

  • 20. High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans.
    Lee H, Swanson P, Shorty VS, Zack JA, Rosenblatt JD, Chen IS.
    Science; 1989 Apr 28; 244(4903):471-5. PubMed ID: 2655084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.